Riskpilot← Back to searchSign inGet full accessSurgeon Oy
OYActiveY-tunnus 0922461-7Turkkirata 9-AEngineering activities and related technical consultancy · NACE 7112Est. 199311 employees
Revenue 2024
EUR 309K
-71% vs 2024
EBITDA margin
-12.4%
-155% vs 2024
Equity ratio
30.3%
Financial strength
Net profit 2024
EUR -47K
-365% vs 2024
| Revenue | EUR 309K | -71% |
| EBITDA | EUR -38K | -155% |
| Net profit | EUR -47K | -365% |
| Total assets | EUR 514K | -11% |
| Equity | EUR 156K | -23% |
| Employees | 11 | — |
Legal name
Surgeon Oy
Y-tunnus number
0922461-7
Legal form
Osakeyhtiö
NACE code
7112 · Engineering activities and related technical consultancy
Founded
17. maaliskuuta 1993
Share capital
EUR 8 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja, toimitusjohtaja ja hallituksen varajäsen kukin yksin
Company purpose
Yhtiön toimialana ovat mittaustekniikka, CAD, 3D-mallit, rakennustoiminta, arvopaperi- ja kiinteistösijoittaminen.
Address
Turkkirata 9-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Revenue | 886 | 921 | 1 246 | 1 054 | 309 |
| Staff expenses | −492 | −530 | −703 | −644 | −222 |
| EBITDA | 151 | 161 | 238 | 70 | −38 |
| Depreciation & amort. | −56 | −55 | −37 | −47 | −8 |
| EBIT | 95 | 106 | 201 | 23 | −46 |
| Net financials | — | −0 | −4 | 1 | −0 |
| Profit before tax | 95 | 106 | 196 | 24 | −47 |
| Tax | 21 | 24 | 42 | 6 | −0 |
| Net profit | 75 | 83 | 154 | 18 | −47 |
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Total assets | 774 | 801 | 858 | 578 | 514 |
| Equity | 648 | 627 | 685 | 202 | 156 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 126 | 174 | 174 | 375 | 359 |
| Total debt | 126 | 174 | 174 | 375 | 359 |
EBITDA margin
-12.4%
This company
15.8%
Market median
-178% vs market
20212024
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
20212024
Return on equity
-30.0%
This company
18.4%
Market median
-263% vs market
20212024
Net profit margin
-15.1%
This company
8.1%
Market median
-286% vs market
20212024
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20212024
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2024-09-01 – 2024-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TK Deputy auditor | Deputy auditor | 2012 |
EM Chief Executive Officer | Chief Executive Officer | 2002 |
TH Audit | Audit | 2012 |
| Former (1) | ||
MK Deputy Member | Deputy Member | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2023 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Taratest Oy
Surgeon Oy Board members of Surgeon Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marjo Kaarina Yli-Jaskari | Deputy Member | 0 companies |
| Tapani Kristian Kärkkäinen | Deputy auditor | 0 companies |
| Esa Martti Yli-Jaskari | Chief Executive Officer | 0 companies |
| Tero Heikki Paukku | Audit | 0 companies |
| Tero Kalle Iivari Mäkinen | Chairperson | 0 companies |
| Tuukka Juhani Räsänen | Board of Directors | 0 companies |
| Olli Juhani Aalto | Board of Directors | 0 companies |